國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 851749      Online Users : 1046
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Books/Book Section [0/1]
    Conference Papers/Meeting Abstract [15/19]
    Periodical Articles [96/97]

    Community Statistics


    Item counts issued in 3 years:31(26.50%)
    Items With Fulltext:111(94.87%)

    Download counts of the item
    Download times greater than 0:111(100.00%)
    Download times greater than 100:105(94.59%)
    Total Bitstream Download Counts:46491(0.87%)

    Last Update: 2024-11-28 07:39

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 51-75 of 117. (5 Page(s) Totally)
    << < 1 2 3 4 5 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2019-03-30 CD44 promotes migration and invasion of docetaxel-resistant prostate cancer cells likely via induction of hippo-yap signaling Cells. 2019 Mar 30;8(4):Article number 295.
    2019-03-20 TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility PLoS ONE. 2019 Mar 20;14(3):Article number e0213463.
    2019-03-12 Synchronous vascular endothelial growth factor protein profiles in both tissue and serum identify metastasis and poor survival in colorectal cancer Scientific Reports. 2019 Mar 12;9:Article number 4228.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling Oncogene. 2019 Feb;38(8):1340-1353.
    2019-02 ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-beta-catenin signaling [Erratum: Oncogene. 2019 Feb;38(8):1340-1353.] Oncogene. 2019 Feb;38(8):1354.
    2019-02 Polymorphisms of suppressor of cytokine signaling-3 associated with susceptibility to tuberculosis among Han Taiwanese Cytokine. 2019 Feb;114:11-17.
    2019-01-25 KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis Cell Death and Disease. 2019 Jan 25;10(2):Article number 68.
    2019-01-03 KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC Oncogene. 2019 Jan 3;38(1):17-32.
    2018-12 Down-regulation of ROR2 promotes prostate cancer metastasis through regulation of miRNAs on PIAS3 expression Cancer Science. 2018 Dec;109(Suppl. 2):443.
    2018-12 KDM4C promotes prostate cancer metastasis via modulation of c-Myc and metabolic enzymes Cancer Science. 2018 Dec;109(Suppl. 2):1241.
    2018-12 CD44 promotes migration ability of docetaxel-resistant prostate cancer cells via induction of Hippo-Yap signaling Cancer Science. 2018 Dec;109(Suppl. 2):990.
    2018-12 Caffeic Acid Phenethyl Ester (CAPE) suppresses protein expression level of AR-V7 in human prostate cancer Cancer Science. 2018 Dec;109(Suppl. 2):995.
    2018-12 Different role of androgen receptor in regulation of prostate cancer metastasis with or without androgen Cancer Science. 2018 Dec;109(Suppl. 2):996.
    2018-12 Rooibos suppresses the proliferation of human castration-resistant prostate cancer cells Cancer Science. 2018 Dec;109(Suppl. 2):575.
    2018-12 ACTL6a promotes metastasis and predicts poor prognosis of prostate cancer via regulation of YAP and cancer stemness Cancer Science. 2018 Dec;109(Suppl. 2):244.
    2018-12 The anti-proliferative effect of CAPE on docetaxel-resistant prostate cancer cells Cancer Science. 2018 Dec;109(Suppl. 2):574.
    2018-11 Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5 Cancer Science. 2018 Nov;109(11):3564-3574.
    2018-10 Histone demethylase KDM4C is a novel oncogene and prognostic biomarker for prostate cancer Annals of Oncology. 2018 Oct;29(Suppl. 7):Meeting Abstract O1-19-2.
    2018-01 KDM4C: A novel oncogene and prognostic biomarker for prostate cancer Cancer Science. 2018 Jan;109(Suppl. 1):1073.
    2018-01 Role of ACTL6A in human prostate cancer cell Cancer Science. 2018 Jan;109(Suppl. 1):1074.
    2017-12 Activation of liver X receptor suppresses angiogenesis via induction of ApoD FASEB Journal. 2017 Dec;31(12):5568-5576.
    2017-10 Non-Canonical Wnt receptor ROR2 suppresses prostate cancer metastasis Annals of Oncology. 2017 Oct;28(Suppl. 9):Meeting Abstract P1-284.
    2017-09-19 Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma Scientific Reports. 2017 Sep 19;7:Article number 11893.
    2017-07 YAP promotes myogenic differentiation via the MEK5-ERK5 pathway FASEB Journal. 2017 Jul;31(7):2963-2972.
    2017-04-21 Suppressors of cytokine signaling in tuberculosis PLoS ONE. 2017 Apr 21;12(4):Article number e0176377.

    Showing items 51-75 of 117. (5 Page(s) Totally)
    << < 1 2 3 4 5 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback